Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
zerohash Launches AUTH to Simplify Onchain Movements
-
Euroseas Ltd. Announces a New Time Charter Contract for its 2001-built 2,556 teu Feeder Containership, M/V EM Corfu, and the Sale of its Sister Vessel, M/V Evridiki G
-
BNB Standard Corporation Appoints Alex Odagiu as Chief Executive Officer and Announces Plan to Operate a BNB Chain Validator
-
Bill Gross, the Entrepreneur Behind 175+ Companies, Launches Idealab.ai to Give Away Millions of Business Ideas—and Help People Everywhere Build Them
-
Orion180® Introduces FlexLuxe, Expanding Insurance Options for High-Value Homes
-
Modern Woodmen of America Renews National Patriot Partnership with Wreaths Across America
-
AIOS Tech Inc. Announces Agreement to Acquire SmartCore Holdings in All-Stock Transaction Valued at Approximately US$100 Million
-
TIRI 2026 Annual Conference Advances Investor Relations Through Value and Trust
-
XBiotech Announces Positive Phase II Final Efficacy Results from Investigator-Sponsored TASKIN Trial in Refractory Metastatic Colorectal Cancer
-
NOVARC TO SHOWCASE PHYSICAL AI ON ROBOTIC WELDING SOLUTIONS AT FABTECH 2026
-
Proof and Circle Show How AI Agents Can Prove Who They Act For and Pay in USDC
-
Exyn Technologies Joins National Laboratory-Led Autonomous Mining Project Selected Under DOE’s $29.5 Million Mine of the Future Initiative
-
FSI ANNOUNCES THIRD QUARTER 2026 REVENUE
-
ConnectM Forms Strategic Advisory Board to Drive AI Energy Infrastructure Growth; Appoints Ashland Director Ashish Kulkarni, Former Fortress and Shumway Capital Executive Neil Bhatia, and Las Olas Cap
-
Town Raises $108M Series B at a $1B Valuation to Bring AI Assistants to Whole Teams
-
Burro Grande 44 Named One of TIME's Best Inventions of 2026
-
Beacon Biosignals Partners with Project Sleep to Shorten the Path to Diagnosis for People with Idiopathic Hypersomnia and Narcolepsy
-
MDA Announces 2027 Clinical & Scientific Conference Agenda Featuring AI, Gene Therapy, Patient Data and the Latest Neuromuscular Disease Research
-
Axonius Introduces AI Workforce, Providing Security Teams With Virtual Workers to Act on Verified Data
-
ProSomnus Announces Significant Scientific, Technical, and Advocacy Updates
-
Proponent Becomes an authorized ExxonMobil Aviation Lubricants Distributor in the Americas
-
RxSight Appoints Eye Care Industry Leaders to Drive Commercial Transformation
-
Natalia Shuman Named 2026 Executive Women of New Jersey Salute to the Policy Makers Honoree
-
Other World Computing (OWC) Announces General Availability (GA) Launch of OWC Dock Ejector 2.1
-
Momentive Software's Rich Vallaster Earns IAEE Bob Dallmeyer Educator of the Year Award
-
TerrAscend to Host Third Quarter 2026 Earnings Conference Call
-
Coop Pank AS own shares acquisition transactions
-
Final Safety, Pharmacokinetic and Pharmacodynamic Data from COL-5671 Phase 1 Clinical Study Presented at UEGW
-
Schouw & Co. share buy-back programme, week 42 2026
-
VIVUS Announces Positive Outcome of European Procedure to Extend QSIVA® (Phentermine/Topiramate MR) to Adolescents with Obesity
-
AMOM Becomes AIED: Defiance ETFs Introduces the Defiance LLM Catalyst Momentum ETF
-
Dito Joins the Google Cloud Managed Security Services Partner Program, Bringing AI-Powered Security Operations to Enterprise and Public Sector
-
Rothschild Financial Partners Welcomes Alpha Rising Wealth Management
-
Celebree School President and CEO Richard Huffman Elected to International Franchise Association Board of Directors
-
Timeero Launches MCP Server to Bring Workforce Data Into AI Assistants
-
Daily AI Use Nearly Doubles Among Marketers as Measurement Lags
-
Dickinson Brands Inc. Celebrates Sixth Annual National Witch Hazel Day With Multi-Brand Consumer Sweepstakes
-
Daré Bioscience Sponsors HERmedicine Educational Program for Clinicians on Managing Menopause After Breast Cancer
-
Celiac Disease Market Analysis 2034: Industry Trends, Market Size, and Emerging Therapeutic Developments – DelveInsight | Zedira, Dr. Falk Pharma, Takeda, ImmunoGenX, Provention Bio, Sanofi
-
BILL Launches New Suite of AI Capabilities to Put Finance Teams in Control of AI and Protect Every Dollar
-
Ama La Vida Launches Retirement Coaching to Help People Plan Their Next Chapter Beyond Finances
-
Acme United to Release Third Quarter 2026 Financial Results on October 27, 2026
-
Nasopharyngeal Carcinoma Market Analysis 2034: Industry Trends, Market Size, and Emerging Therapeutic Developments – DelveInsight | BieGene, Famitinib, Tessa Therapeutics, Chia Tai Tianqing Pharma
-
BILL Surpasses $2 Trillion in Cumulative Total Payment Volume
-
Venue Two Eleven Launches as Premier Event Space at the Museum of the Oregon Territory
-
dsm-firmenich shareholders elect Richard Ridinger as Chairman of the Board of Directors
-
Match2 Unveils Universal Candidate Profile™ Enhancements and Expands Connected Talent Network Across SAP, Phenom and Leading HR Platforms
-
Under The Motto "Distribution Is The New Moat," Nomada Fund Launches As The World's First New Media Fund
-
Stage IV Cancer Survivor Shares How Illness Reshaped His Faith, Priorities and Perspective
-
New Chapter Recovery NJ Reinforces Commitment to Quality Care with Joint Commission Accreditation and LegitScript Certification
